These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26759084)

  • 1. Early Presentation of Hyperinsulinism/Hyperammonemia Syndrome in Three Serbian Patients.
    Sarajlija A; Milenkovic T; Djordjevic M; Mitrovic K; Todorovic S; Kecman B; Hussain K
    J Clin Res Pediatr Endocrinol; 2016 Jun; 8(2):228-31. PubMed ID: 26759084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene.
    Tran C; Konstantopoulou V; Mecjia M; Perlman K; Mercimek-Mahmutoglu S; Kronick JB
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):873-6. PubMed ID: 25781533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA).
    Fang C; Ding X; Huang Y; Huang J; Zhao P; Hu J
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):385-8. PubMed ID: 26656609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature.
    Ninković D; Sarnavka V; Bašnec A; Ćuk M; Ramadža DP; Fumić K; Kušec V; Santer R; Barić I
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1083-8. PubMed ID: 27383869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome.
    Balasubramaniam S; Kapoor R; Yeow JH; Lim PG; Flanagan S; Ellard S; Hussain K
    J Pediatr Endocrinol Metab; 2011; 24(7-8):573-7. PubMed ID: 21932603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations.
    Kapoor RR; Flanagan SE; Fulton P; Chakrapani A; Chadefaux B; Ben-Omran T; Banerjee I; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2009 Nov; 161(5):731-5. PubMed ID: 19690084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinism hyperammonaemia (HI/HA) syndrome due to GLUD1 mutation: phenotypic variations ranging from late presentation to spontaneous resolution.
    Brandt A; Agarwal N; Giri D; Yung Z; Didi M; Senniappan S
    J Pediatr Endocrinol Metab; 2020 May; 33(5):675-679. PubMed ID: 32229669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of glutamate dehydrogenase mutations in Japanese patients with congenital hyperinsulinism and hyperammonemia syndrome.
    Aso K; Okano Y; Takeda T; Sakamoto O; Ban K; Iida K; Yamano T; Shintaku H
    Osaka City Med J; 2011 Jun; 57(1):1-9. PubMed ID: 22106762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene.
    Corrêa-Giannella ML; Freire DS; Cavaleiro AM; Fortes MA; Giorgi RR; Pereira MA
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):485-9. PubMed ID: 23295286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures and diagnostic difficulties in hyperinsulinism-hyperammonemia syndrome.
    Aka S; Alanay Y; Boodhansingh KE; Stanley CA; Semiz S
    Turk J Pediatr; 2016; 58(5):541-544. PubMed ID: 28621098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two unrelated Chinese patients with hyperinsulinism /hyperammonemia (HI/HA) syndrome due to mutations in glutamate dehydrogenase gene.
    Diao C; Chen S; Xiao X; Wang T; Sun X; Wang O; Song H; Zhang Y; Yu M; Zhang Q; Wang H
    J Pediatr Endocrinol Metab; 2010 Jul; 23(7):733-8. PubMed ID: 20857847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
    De Los Santos-La Torre MA; Del Águila-Villar CM; Lu-de Lama LR; Nuñez-Almache O; Chávez-Tejada EM; Espinoza-Robles OA; Pinto-Ibárcena PM; Calagua-Quispe MR; Azabache-Tafur PM; Tucto-Manchego RM
    J Pediatr Endocrinol Metab; 2023 Feb; 36(2):207-211. PubMed ID: 36476334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.
    Su C; Liang XJ; Li WJ; Wu D; Liu M; Cao BY; Chen JJ; Qin M; Meng X; Gong CX
    J Diabetes Res; 2018; 2018():2802540. PubMed ID: 30306091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome.
    Bahi-Buisson N; Roze E; Dionisi C; Escande F; Valayannopoulos V; Feillet F; Heinrichs C; Chadefaux-Vekemans B; Dan B; de Lonlay P
    Dev Med Child Neurol; 2008 Dec; 50(12):945-9. PubMed ID: 19046187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations.
    Raizen DM; Brooks-Kayal A; Steinkrauss L; Tennekoon GI; Stanley CA; Kelly A
    J Pediatr; 2005 Mar; 146(3):388-94. PubMed ID: 15756227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report.
    Odom J; Gieron-Korthals M; Shulman D; Newkirk P; Prijoles E; Sanchez-Valle A
    J Med Case Rep; 2016 Feb; 10():25. PubMed ID: 26839063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hyperinsulinism/hyperammonemia syndrome.
    Palladino AA; Stanley CA
    Rev Endocr Metab Disord; 2010 Sep; 11(3):171-8. PubMed ID: 20936362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intractable absence seizures in hyperinsulinism-hyperammonemia syndrome.
    Nakano K; Kobayashi K; Okano Y; Aso K; Ohtsuka Y
    Pediatr Neurol; 2012 Aug; 47(2):119-22. PubMed ID: 22759688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.
    Grimaldi M; Karaca M; Latini L; Brioudes E; Schalch T; Maechler P
    Hum Mol Genet; 2017 Sep; 26(18):3453-3465. PubMed ID: 28911206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators.
    Stanley CA; Fang J; Kutyna K; Hsu BY; Ming JE; Glaser B; Poncz M
    Diabetes; 2000 Apr; 49(4):667-73. PubMed ID: 10871207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.